Switching to Degludec From Other Basal Insulins Is Associated With Reduced Hypoglycemia Rates: A Prospective Study

Lignende værker

• Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study
  af: de Valk, Harold W., et al.
  Udgivet: (2020)
• Reduced Rates of Hypoglycemia in Type 1 or Type 2 Diabetes After Switching to Insulin Degludec: Results from the Italian Cohort of the ReFLeCT Study
  af: Fadini, Gian Paolo, et al.
  Udgivet: (2020)
• Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy
  af: Langer, Jakob, et al.
  Udgivet: (2019)
• Severe Hypoglycemia in Adults With Type 1 Diabetes After Switching to Insulin Degludec
  af: Akturk, Halis Kaan, et al.
  Udgivet: (2017)
• Switching “Real-World” Diabetes Patients to Degludec from Other Basal Insulins Provides Different Clinical Benefits According to Their Baseline Glycemic Control
  af: Tentolouris, Nikolaos, et al.
  Udgivet: (2019)